T86.812
Lung transplant infection
Clinical Classification Guidelines
Use Additional Code
- code to specify infection
Medical Intelligence & Overview
A lung transplant infection occurs when harmful microorganisms, such as bacteria, viruses, or fungi, infect the lungs after a lung transplant procedure. This type of infection can pose serious health risks to transplant recipients because their immune systems are often weakened by medications used to prevent organ rejection. Recognizing and managing these infections promptly is crucial to preserving lung function and overall health post-transplant.
Causes & Symptoms
Clinical Causes: Exposure to infectious agents through respiratory droplets or contact Immunosuppressive medications that lower immune defenses, increasing vulnerability Pre-existing infections prior to transplant that may not have been fully eradicated Hospital-acquired infections acquired during or after medical procedures Contamination of equipment or environment during care or procedure
Key Symptoms: Persistent cough or worsening cough Fever or chills Shortness of breath or difficulty breathing Chest pain or discomfort Fatigue or general weakness Coughing up phlegm or blood Reduced exercise tolerance
Diagnostic & Treatment
Diagnosis Path: Diagnosing a lung transplant infection involves a combination of clinical assessment and laboratory tests. Healthcare professionals may perform:
Treatment Protocols: Treatment strategies focus on eliminating the infection and supporting lung health. Common approaches include:
Clinical Advice & FAQs
Billing Guidance
Is T86.812 a billable ICD-10 code?
Yes, T86.812 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T86.812?
Clinical documentation must specify the nature of Lung transplant infection and any associated comorbidities for accurate reporting.
Cite this Clinical Reference